Top Tweets for #InnovatingAccess
We're adding years to life. But are we adding life to those years?
People are living longer around the world, yet healthy years don't always increase at the same pace. Expanding access to care can help more people live healthier lives.
#WorldPopulationDay #InnovatingAccess
Samsung Bioepis is honored to have received seven accreditations in recognition of our supportive and inclusive company culture. #GreatPlaceToWork #InnovatingAccess
Gillian Woollett reviewed regulatory trends for biosimilars around the world at the Global Bio Conference 2025. Samsung Bioepis is proud to contribute to the discussion on the regulatory environment at global platforms like GBC.
#GBC2025 #PassionForHealth #InnovatingAccess
This #PsoriasisActionMonth, we shed light on a chronic condition that affects over 60 million people worldwide. By advancing biosimilar therapies in immunology, we empower psoriasis patients by improving their access to effective treatments.
#PassionForHealth #InnovatingAccess
Non-small cell lung cancer accounts for 85% of all lung cancers and is often detected late. Biosimilars provide NSCLC patients with wider access to more affordable and effective treatments.
#WorldLungCancerDay #InnovatingAccess #Oncology
Dive into our Q3 2025 Biosimilar Market Report for insights on the latest US approvals, pricing shifts, and policy moves that are reshaping access and competition.
π Read the full report here: https://t.co/EVvapTQmzq
#Biosimilars #PassionforHealth #InnovatingAccess
π There are so many emojis for expressing how happy you are. πππ₯°ππ In the same way, we supportπ¬ providing multiple options for treatingπ©Ή the same condition, as we expand patient accessποΈ through biosimilars.πβ
#WorldEmojiDay #InnovatingAccess #PassionForHealth
The new ICH guideline streamlines the biosimilar development process. Samsung Bioepis will continue to support the IGBA and ICH and their efforts to improve the clarity and efficiency of biosimilar development.
https://t.co/cIn2OKiPvC
#PassionForHealth #InnovatingAccess
At the @EHA_Hematology Congress 2025, Samsung Bioepis reiterated its commitment to shaping the future of advanced therapeutic options in hematology.
We will continue to share knowledge and improve access for patients.
#EHA2025 #PassionForHealth #InnovatingAccess
Samsung Bioepis participated in the European Renal Association Congress 2025.
We will continue to provide innovative biosimilar treatments, working to create more sustainable healthcare systems.
#ERA25 #PassionForHealth #InnovatingAccess
Samsung Bioepis announced a strategic partnership with NIPRO Corporation that will expand Samsung Bioepis' presence into Japan, with the development and commercialization of biosimilars.
π https://t.co/Am0EM3Ip7A
#PassionForHealth #InnovatingAccess
We are partnering with Teva Pharmaceuticals to bring our latest biosimilar to the US market. Together, we are expanding access to high-quality treatment for patients with rare diseases.
Catch the latest updates here: https://t.co/CszswXRrq2 #PassionForHealth #InnovatingAccess
We are continuing our work to expand access to quality-assured, safe and effective biosimilars to improve patientβs quality of life and support sustainability of healthcare systems. Check out our latest regulatory milestones: https://t.co/eI2aUh1H4E
#InnovatingAccess
New on our blog! Discover the science behind biosimilar extrapolation. Learn about the rigorous research that supports biosimilar approval and patient safety. π Read more: https://t.co/9ZEPmxrVmW
#Biosimilars #PassionforHealth #InnovatingAccess
Check out our Regulatory Strategy and Policy Team's perspective on interchangeability published in @GABIOnline_. Read GaBI paper: https://t.co/6EFmeAUwCW and our blog post: https://t.co/hBe64NaYlJ
#Biosimilars #InnovatingAccess #PassionForHealth
In a recent interview withΒ @BioWorld, Thomas Newcomer, our VP and Head of U.S. Market Access, discussed the current state of the adalimumab biosimilar market one-year after #biosimilars launched.Β Read more here: https://t.co/hFmh2s42EZ Β #InnovatingAccess #PassionForHealth
Inflammatory Bowel Disease (IBD) affects 10 million people around the world showing #IBDhasnoborders. This #WorldIBDDay2024, weβre committed and working to help patients worldwide manage this chronic condition. #InnovatingAccess
New to #biosimilars? π€ Health care providers (HCP) are your go-to source for information. Try the #quiz below and learn how they can help.
#InnovatingAccess
[Quiz]
How can HCPs educate patients on biosimilars? By β
Today marks the 12th anniversary of Samsung Bioepis. We've been dedicated to #InnovatingAccess to #biosimilars since 2012. We are so proud of how far weβve come and are very excited about where we are headed. #PassionforHealth
Looking back to look forward. In a recent op-ed @Pharmacy_Times, our VP Tom Newcomer reflects on what the past year has taught us about #biosimilar adoption in the US. Read more here: https://t.co/pt7tcnAoeJ #PassionForHealth #InnovatingAccess
Last Seen Hashtags on Sotwe
momsonincest
Seen from South Africa
γγγγεΌ
Seen from Italy
slavegirls
Seen from France
FirstRollerCoasterRide
Seen from United States
nolimit #exny #momson #xlii
Seen from Singapore
ΰΉΰΈΰΈΰΉΰΉΰΈ₯ΰΈΰΉ
Seen from Netherlands
ai #twink
Seen from Germany
κΉμν
Seen from Colombia
madrereal
Seen from Poland
omegle
Seen from Poland
Most Popular Users
Elon Musk 
@elonmusk
241.3M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
113.1M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.3M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.5M followers
KATY PERRY
@katyperry
89.1M followers
Taylor Swift
@taylorswift13
83.1M followers
Lady Gaga
@ladygaga
74.5M followers
Virat Kohli
@imvkohli
72.1M followers
Kim Kardashian
@kimkardashian
70.5M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
65M followers
Bill Gates
@billgates
64.7M followers
The Ellen Show
@theellenshow
62.4M followers
Selena Gomez
@selenagomez
62.2M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers